About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Globus Medical’s Q2 Earnings Call: Our Top 5 Analyst Questions

GMED Cover Image

Globus Medical delivered results that exceeded Wall Street’s expectations in the second quarter, with the market responding favorably to its 18.4% revenue growth and improved profitability. Management credited the strong performance to the resurgence of its U.S. Spine business, new product launches, and the successful resolution of earlier supply chain constraints. CEO Keith Pfeil highlighted the positive momentum in core trauma and enabling technologies, noting, “Our U.S. Spine business led the way commercially, growing 5.7% as reported.” Recent acquisitions and operational improvements also contributed to the company’s performance this quarter.

Is now the time to buy GMED? Find out in our full research report (it’s free).

Globus Medical (GMED) Q2 CY2025 Highlights:

  • Revenue: $745.3 million vs analyst estimates of $740.2 million (18.4% year-on-year growth, 0.7% beat)
  • Adjusted EPS: $0.86 vs analyst estimates of $0.75 (14.1% beat)
  • Adjusted EBITDA: $208.7 million vs analyst estimates of $199.1 million (28% margin, 4.8% beat)
  • The company reconfirmed its revenue guidance for the full year of $2.85 billion at the midpoint
  • Management reiterated its full-year Adjusted EPS guidance of $3.15 at the midpoint
  • Operating Margin: 10.2%, up from 7.9% in the same quarter last year
  • Constant Currency Revenue rose 17.6% year on year (117% in the same quarter last year)
  • Market Capitalization: $8.48 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Globus Medical’s Q2 Earnings Call

  • Matthew Miksic (Barclays): Asked about progress with Nevro cost actions and sale force integration. CEO Keith Pfeil described early cost controls and positive sales force engagement, emphasizing stability and long-term growth focus.
  • Vik Chopra (Wells Fargo): Queried about the launch plans for the augmented reality headset. Pfeil said product supply is ready, with launch planning underway and integration into the Excelsius ecosystem as a priority.
  • Shagun Singh Chadha (RBC): Asked about leadership changes and internal succession planning. Executive Chairman David Paul highlighted deliberate succession planning and consistent board involvement, affirming management stability.
  • Matthew Charles Taylor (Jefferies): Questioned the pathway to Nevro’s profitability and earnings accretion. CFO Kyle Kline noted ongoing synergy actions and a cautious approach, expecting more clarity after further integration.
  • David Saxon (Needham & Company): Inquired about the timeline for achieving mid-70s gross margins. Pfeil outlined a 12- to 18-month timeline, driven by manufacturing in-sourcing and process improvements.

Catalysts in Upcoming Quarters

Looking ahead, our analysts will monitor (1) the pace of Nevro integration and resulting cost synergies in both SG&A and R&D, (2) adoption rates for new enabling technology products, including the Excelsius XR headset, and (3) sustained momentum in the U.S. Spine and trauma segments as new products and sales initiatives are rolled out. Execution in international market integration and manufacturing upgrades will also be important signposts.

Globus Medical currently trades at $62.79, up from $54.12 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).

Our Favorite Stocks Right Now

Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.

The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.